Huadong Medicine Co., Ltd (SHE:000963)

China flag China · Delayed Price · Currency is CNY
26.41
-1.48 (-5.31%)
Jun 26, 2026, 3:04 PM CST
-34.85%
Market Cap 46.32B
Revenue (ttm) 44.06B
Net Income (ttm) 3.50B
Shares Out 1.75B
EPS (ttm) 2.00
PE Ratio 13.23
Forward PE 10.35
Dividend 0.93 (3.33%)
Ex-Dividend Date Jun 10, 2026
Volume 23,671,608
Average Volume 15,667,281
Open 27.61
Previous Close 27.89
Day's Range 26.41 - 28.33
52-Week Range 26.41 - 47.36
Beta 0.12
RSI 29.46
Earnings Date Aug 14, 2026

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. The company operates through Pharmaceutical Manufacturing, Pharmaceutical Distribution, Medical Aesthetics, and Industrial Microbiology segments. It offers Chinese medicine, immunosuppressive agents, endocrine, digestive system, antineoplastic, cardiovascular, antibiotic drugs, medical beauty field, and medical devices, as well as engages in pharmaceutical logistics and industrial microbiology a... [Read more]

Sector Healthcare
Founded 1993
Employees 19,095
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000963
Full Company Profile

Financial Performance

In 2025, Huadong Medicine's revenue was 43.61 billion, an increase of 4.07% compared to the previous year's 41.91 billion. Earnings were 3.41 billion, a decrease of -2.78%.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for 000963 stock is "Buy." The 12-month stock price target is ¥47.12, which is an increase of 78.42% from the latest price.

Price Target
¥47.12
(78.42% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Huadong Medicine Annual report: Q4 2025

Huadong Medicine has published its Q4 2025 annual report on April 23, 2026.

2 months ago - Filings

Huadong Medicine Quarterly report: Q1 2026

Huadong Medicine has published its Q1 2026 quarterly earnings report on April 23, 2026.

2 months ago - Filings

CARsgen Therapeutics Announces 2025 Annual Results

SHANGHAI , March 6, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2025 Annual Res...

4 months ago - Benzinga

Huadong Medicine Quarterly report: Q3 2025

Huadong Medicine has published its Q3 2025 quarterly earnings report on December 3, 2025.

7 months ago - Filings

Huadong Medicine Quarterly report: Q2 2025

Huadong Medicine has published its Q2 2025 quarterly earnings report on August 21, 2025.

11 months ago - Filings

Huadong Medicine Annual report: Q4 2024

Huadong Medicine has published its Q4 2024 annual report on July 8, 2025.

1 year ago - Filings

Huadong Medicine Quarterly report: Q1 2025

Huadong Medicine has published its Q1 2025 quarterly earnings report on July 8, 2025.

1 year ago - Filings